BIM
SGNT

Bogle Investment Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bogle Investment Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-41,007
Closed -$499K – 544
2016
Q1 		$499K Buy
+41,007
New +$575K 0.03% 334
2015
Q1 		– Sell
-16,785
Closed -$421K – 468
2014
Q4 		$421K Sell
16,785
-41,710
-71% -$1.22M 0.03% 304
2014
Q3 		$1.82M Buy
+58,495
New +$1.58M 0.12% 191
2014
Q1 		– Sell
-168,268
Closed -$4.27M – 434
2013
Q4 		$4.27M Hold
168,268
– – 0.36% 102
2013
Q3 		$3.43M Buy
168,268
+139,915
+493% +$3.12M 0.35% 109
2013
Q2 		$594K Buy
+28,353
New +$507K 0.07% 230

Other funds holding SGNT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bogle Investment Management's SGNT Position: Q2 2016 in Review

Bogle Investment Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2016, closing a stake of 41,007 shares — an estimated $499K sold.

Bogle Investment Management first reported a position in SGNT in Q2 2013 and held it in 6 quarters. The position peaked at $4.27M in Q4 2013. 128 funds tracked by Wall St. Rank hold SGNT as of Q2 2016.

  • Bogle Investment Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Bogle Investment Management sold 41,007 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2016, an estimated $499K.
  • Bogle Investment Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Bogle Investment Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $4.27M in Q4 2013.
  • 128 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2016.

Based on Bogle Investment Management's 13F filing for Q2 2016, filed 12 Aug 2016.